640 related articles for article (PubMed ID: 29669190)
21. Utility of the Milan system for reporting salivary gland cytopathology: A retrospective 5 years study.
Chirmade J; Kothari K; Naik L; Agnihotri M
Diagn Cytopathol; 2021 Apr; 49(4):500-508. PubMed ID: 33444484
[TBL] [Abstract][Full Text] [Related]
22. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
Foschini MP; Krausz T
Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic accuracy and pitfalls in fine needle aspiration cytology of salivary glands: a study of 113 cases].
Lü BJ; Zhu J; Gao L; Xie L; Xu JY; Lai MD
Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):706-10. PubMed ID: 16536312
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of Milan system for reporting salivary gland cytopathology: A prospective study.
Hosseini SM; Resta IT; Baloch ZW
Diagn Cytopathol; 2021 Jul; 49(7):822-831. PubMed ID: 33823076
[TBL] [Abstract][Full Text] [Related]
25. Retrospective application of the Milan System for reporting salivary gland cytopathology: A Cancer Center experience.
Leite AA; Vargas PA; Dos Santos Silva AR; Galvis MM; de Sá RS; Lopes Pinto CA; Kowalski LP; Saieg M
Diagn Cytopathol; 2020 Sep; 48(9):821-826. PubMed ID: 32374949
[TBL] [Abstract][Full Text] [Related]
26. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
27. The Milan System for Reporting Salivary Gland Cytopathology: Assessment of Cytohistological Concordance and Risk of Malignancy.
Jha S; Mitra S; Purkait S; Adhya AK
Acta Cytol; 2021; 65(1):27-39. PubMed ID: 33045705
[TBL] [Abstract][Full Text] [Related]
28. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): An international effort toward improved patient care-when the roots might be inspired by Leonardo da Vinci.
Rossi ED; Faquin WC
Cancer Cytopathol; 2018 Sep; 126(9):756-766. PubMed ID: 30264905
[TBL] [Abstract][Full Text] [Related]
29. The utility of the Milan System as a risk stratification tool for salivary gland fine needle aspiration cytology specimens.
Song SJ; Shafique K; Wong LQ; LiVolsi VA; Montone KT; Baloch Z
Cytopathology; 2019 Jan; 30(1):91-98. PubMed ID: 30303566
[TBL] [Abstract][Full Text] [Related]
30. Multi-institutional validation of a modified scheme for subcategorizing salivary gland neoplasm of uncertain malignant potential (SUMP).
Hang JF; Lee JJL; Nga ME; Higuchi K; Hirata Y; Wu HH; Allison DB; Gilbert JD; Lin O; Saieg M; de Arruda AF; Chen YA; Huang EC; Manucha V
Cancer Cytopathol; 2022 Jul; 130(7):511-522. PubMed ID: 35637575
[TBL] [Abstract][Full Text] [Related]
31. The effectiveness of the Milan system for risk stratification of salivary gland lesions: The 10-year cytohistopathological correlation results of salivary gland FNA cytology at a tertiary center.
Aksoy Altinboga A; Yildirim F; Ahsen H; Kiran MM; Kesici GG; Yuce G
Diagn Cytopathol; 2021 Aug; 49(8):928-937. PubMed ID: 34009744
[TBL] [Abstract][Full Text] [Related]
32. Cytohistologic correlation of basaloid salivary gland neoplasms: Can cytomorphologic classification be used to diagnose and grade these tumors?
Gargano SM; Sebastiano C; Solomides CC; Griffith CC; HooKim K
Cancer Cytopathol; 2020 Feb; 128(2):92-99. PubMed ID: 31742931
[TBL] [Abstract][Full Text] [Related]
33. Utility of the Milan System for Reporting Salivary Gland Cytology, with focus on the incidence and histologic correlates of atypia of undetermined significance (AUS) and salivary gland neoplasm of uncertain malignant potential (SUMP): A 3-year institutional experience.
Cormier CM; Agarwal S
Cancer Cytopathol; 2022 Apr; 130(4):303-312. PubMed ID: 34875145
[TBL] [Abstract][Full Text] [Related]
34. Application of the Milan System for Reporting Salivary Gland Cytopathology: A retrospective study in a tertiary institute.
Chen YA; Wu CY; Yang CS
Diagn Cytopathol; 2019 Nov; 47(11):1160-1167. PubMed ID: 31313521
[TBL] [Abstract][Full Text] [Related]
35. Application of the Milan System for Reporting Salivary Gland Cytopathology: A 10-Year Experience in a Single Japanese Institution.
Hirata Y; Higuchi K; Tamashiro K; Koja K; Yasutomi Y; Matsuzaki A; Yoshimi N
Acta Cytol; 2021; 65(2):123-131. PubMed ID: 33113539
[TBL] [Abstract][Full Text] [Related]
36. Risk stratification of salivary gland cytology utilizing the Milan system of classification.
Savant D; Jin C; Chau K; Hagan T; Chowdhury M; Koppenhafer J; Kercy M; Laser A; Gimenez C; Das K
Diagn Cytopathol; 2019 Mar; 47(3):172-180. PubMed ID: 30479006
[TBL] [Abstract][Full Text] [Related]
37. Retrospective assessment of the effectiveness of the Milan system for reporting salivary gland cytology: A systematic review and meta-analysis of published literature.
Farahani SJ; Baloch Z
Diagn Cytopathol; 2019 Feb; 47(2):67-87. PubMed ID: 30375201
[TBL] [Abstract][Full Text] [Related]
38. Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland.
Millan N; Tjendra Y; Zuo Y; Jorda M; Garcia-Buitrago M; Velez-Torres JM; Gomez-Fernandez C
Cancer Cytopathol; 2022 Dec; 130(12):949-954. PubMed ID: 35913415
[TBL] [Abstract][Full Text] [Related]
39. Putting morphology to the test: An established classification scheme reliably stratifies salivary gland cytology by risk of malignancy with substantial interobserver agreement.
Lubin DJ; Griffith CC; Buonocore DJ; Wei XJ; Lin O
Cancer Cytopathol; 2021 Apr; 129(4):291-303. PubMed ID: 33136345
[TBL] [Abstract][Full Text] [Related]
40. Retrospective implementation of the Milan system for reporting salivary gland cytopathology; a review of 5 years in a specialized cancer center.
Jaber OI; Shawash SI
Diagn Cytopathol; 2021 Feb; 49(2):187-194. PubMed ID: 33002325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
